New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M Del Campo, H Zetterberg, S Gandy… - Alzheimer's & …, 2022 - Wiley Online Library
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …
被引用次数：27 相关文章

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M del Campo, H Zetterberg, S Gandy… - Alzheimer's and …, 2022 - pure.johnshopkins.edu
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia.

M Del Campo, H Zetterberg, S Gandy… - … & Dementia: the …, 2022 - europepmc.org
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …
[PDF] archive.org

[PDF][PDF] New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M del Campo, H Zetterberg, S Gandy, CU Onyike… - 2022 - scholar.archive.org
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M del Campo, H Zetterberg… - Alzheimer s & …, 2022 - researchinformation.amsterdamumc …
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M del Campo, H Zetterberg, S Gandy… - Alzheimer's & …, 2022 - ddd.uab.cat
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M del Campo, H Zetterberg, S Gandy… - Alzheimer's and …, 2022 - discovery.ucl.ac.uk
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M Del Campo, H Zetterberg… - … & dementia: the …, 2022 - pubmed.ncbi.nlm.nih.gov
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …

New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

A Lleó, M del Campo, H Zetterberg… - Alzheimer's and …, 2022 - portalrecerca.uab.cat
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …
[HTML] nih.gov

[HTML][HTML] New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

M del Campo, H Zetterberg, S Gandy… - Alzheimer's & …, 2022 - ncbi.nlm.nih.gov
Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with
different phenotypes, genetic backgrounds, and pathological states. Its clinicopathological …